Declaration of interest
S.J. Szefler has consulted for Aerocrine, Astra Zeneca, Boehringer-Ingelheim, Daiichi Sankyo, Glaxo Smith Kline, Genentech, Novartis, Roche, and Teva and has received research support from the National Institutes of Health, the National Heart, Lung and Blood Institute, GlaxoSmithKline, and the Colorado Cancer, Cardiovascular and Pulmonary Disease Program. He is also a former member of the Global Initiative for Asthma Scientific Committee and the National Asthma Education and Prevention Expert Panel 3.
Additional information
Notes on contributors
Jessica Hollenbach
J.P. Hollenbach, M. Villarreal, C. Langton, H. Mitchell, and M.M. Cloutier received research support from GlaxoSmithKline to conduct the original school-based asthma study referenced in this manuscript.